Clinical trial
Effects of Immunosuppression on HCV Recurrence After Living Donor Liver…
NCT00469131 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other · Completed
Key facts
| NCT number | NCT00469131 |
|---|---|
| Title | Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid |
| Official title | Randomized Comparative Study on Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparison Between Tacrolimus + MMF and Tacrolimus + Steroid |
| Lead sponsor | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other |
| Collaborators | Kyoto University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C, Liver Cirrhosis |
| Intervention type | Drug |
| Interventions | tacrolimus + steroid, tacrolimus + mycophenolate mofetil |
| Enrollment | 79 |
| Start date | Sep 1, 2003 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | May 4, 2007 |
| Last update posted | Sep 14, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: